Downstream Processing

31. Ultralow Particulate Bottles And Carboys: Where Being Particular About Particulates Is Critical 5/27/2025

    Optimize your operations with ready-to-use, meticulously prepared containers. Learn how our commitment to cleanliness reduces risks and supports your most critical requirements.

32. Bioprocessing Equipment And Automation Product Portfolio Overview 5/19/2025

    Accelerate biotherapeutic development with innovative bioprocessing equipment and automation solutions that feature single-use mixers, bioreactors, and more to streamline workflows and speed products to market.

33. Enhancing AAV Purification In Gene Therapy Manufacturing 6/2/2025

    Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.

34. What Is The DynaChrom™ Single-Use Chromatography System? 3/21/2024

    This chromatography system offers a flexible solution, paired with an advanced software platform, allowing easy integration with downstream process automation.

35. Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA 11/4/2025

    In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.

36. CaptureSelect Affinity Chromatography 11/4/2025

    30-second video sharing a visualization of our CaptureSelect affinity chromatography capability. The target protein binds with VHH molecules immobilized on the chromatography beads, non-target proteins are removed, and the eluted fraction contains a high yield of purified target protein.

37. Addressing Post-Translational Modifications In Novel Protein Therapeutics 9/13/2024

    Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.

38. Driving The Expansion Of mRNA Into The Therapeutic Sphere 6/5/2025

    Discover the next wave of mRNA therapeutics and how emerging technologies are solving key challenges in downstream processing and analysis to enhance both safety and efficacy.

39. Innovation Of Novel Purification Strategies 6/2/2025

    In this webinar, we present the development of a novel scavenging resin for clusterin, a persistent CHO host cell protein commonly observed in monoclonal antibody manufacturing processes.

40. Affinity Resins Overview 6/16/2025

    We have developed a unique portfolio of affinity resins to help you develop biosimilars, biobetters, and other types of recombinant proteins. These affinity resins can be used for clinical and commercial production.